Literature DB >> 31966407

Mammary epithelioid myofibroblastoma mimicking invasive carcinoma: case report and literature review.

Qiu-Yang Jing1, Li Liu2, Biao Zhong3, Lu-Hong Zhu2, Zhi-Ying Chen2, Wei Liu4, Ya-Ni Wei1, Bing Wei1.   

Abstract

Myofibroblastoma (MFB) of the breast is a rare benign neoplasm, which exhibits several morphologic variants and presents diagnostic dilemmas for pathologists. Here, we describe a case of a 42-year-old female patient diagnosed as epithelioid MFB. This painless tumor was well-circumscribed and found in the left breast for three months. Histologically, this tumor was predominantly composed of epithelioid cells, which arranged as single cells or small clusters, and formed a cellular nodule. Tumor stroma was collagenized, with scattered myxoid areas. This case was misinterpreted as invasive lobular carcinoma in the original diagnosis. Immunohistochemical profile demonstrated positivity for desmin, SMA, calponin, CD34 and hormone receptors, whereas pan-CK, CK7, CK8, CK34bE12, CK5/6, EMA, p63 and S-100 were negative, confirming the diagnosis of epithelioid MFB. Awareness of this unusual variant and careful integration of clinicopathologic findings would be critical to diagnosis this challenging lesion and avoid potential diagnostic pitfalls. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Breast; differential diagnosis; epithelioid myofibroblastoma; immunohistochemistry

Year:  2017        PMID: 31966407      PMCID: PMC6965787     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  2 in total

1.  Epithelioid myofibroblastoma of the breast: A case report and review of the literature.

Authors:  Takahiro Inaishi; Takahiko Sakuma; Tomoki Fukuoka; Shu Ichihara
Journal:  Int J Surg Case Rep       Date:  2022-07-02

2.  A Rare Case of Epithelioid Myofibroblastoma of Breast Mimicking Lobular Carcinoma on Trucut Biopsy: a Diagnostic Pitfall and Literature Review.

Authors:  Amrita Talwar; Swasti Jain; Arvind Ahuja; Purnima Paliwal
Journal:  Indian J Surg Oncol       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.